Post Doctoral Fellowship: Global Patient Safety at Eli Lilly and Company

Indianapolis, Indiana, United States

Apply Now

Not SpecifiedCompensation

InternshipExperience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, Healthcare, BiotechnologyIndustries

Requirements

Ambitious post-doctoral scientist
Strong research skills
Strong communication skills

Responsibilities

Utilize innovative machine learning (ML) and rare event modeling techniques to investigate risk factors and protective factors associated with serious or severe drug adverse events
Initially focus on neuroscience, with subsequent extension of methodology to other critical events and therapeutic areas
Enhance understanding of drivers behind safety concerns and strengthen ability to evaluate benefit-risk profiles of investigational and marketed therapies
Support activities of the Global Patient Safety (GPS) Medical organization, including characterizing and communicating safety profiles, assessing benefit-risk, and planning/measuring risk minimization measures
Generate scientific data revealing new clinical insights into risk factors driving adverse events of special interest for key Lilly products
Adapt methodology to other compounds both in development and on the market
Collaborate with colleagues in Medical, Statistics, Toxicology, and Advanced Intelligence

Skills

Machine Learning

Rare Event Modeling

Research

Data Analysis

Statistical Modeling

Python

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free